Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Asset Writedowns and Impairment (2016 - 2025)

STRATA Skin Sciences' Asset Writedowns and Impairment history spans 13 years, with the latest figure at -$166000.0 for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 8.29% to -$166000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$142000.0, a 186.06% decrease, with the full-year FY2024 number at -$182000.0, changed N/A from a year prior.
  • Asset Writedowns and Impairment hit -$166000.0 in Q3 2025 for STRATA Skin Sciences, down from $166000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for SSKN hit a ceiling of $205000.0 in Q4 2023 and a floor of -$181000.0 in Q3 2024.
  • Historically, Asset Writedowns and Impairment has averaged -$4352.9 across 5 years, with a median of -$14000.0 in 2021.
  • The widest YoY moves for Asset Writedowns and Impairment: up 700.0% in 2021, down 2800.0% in 2021.
  • Tracing SSKN's Asset Writedowns and Impairment over 5 years: stood at $27000.0 in 2021, then surged by 207.41% to $83000.0 in 2022, then surged by 146.99% to $205000.0 in 2023, then plummeted by 169.27% to -$142000.0 in 2024, then fell by 16.9% to -$166000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for SSKN at -$166000.0 in Q3 2025, $166000.0 in Q2 2025, and -$142000.0 in Q4 2024.